Neuland Laboratories (NEULANDLAB) Share Price Falls 2.34% as Valuation Stays in Focus
- October 1, 2026
- Posted by: Kunal Singla
- Category: News
Neuland Laboratories Share Price is trading at Rs 18,775 after a 2.34% decline, with market capitalisation at Rs 24,664.82 crore. The move leaves Neuland Laboratories Share Price as one of the notable healthcare stock moves in today’s market, even though the latest Univest figures do not establish a company-specific trigger. The price move is confirmed in Univest data; a company-specific reason has not been established. For readers tracking Neuland Laboratories Share Price Today, the key context is that the stock remains a Large Cap in the Healthcare sector and continues to command premium valuation metrics. Univest also shows strong profitability ratios alongside a price gap from the previous close, so the focus shifts from a headline fall to what the numbers say about value, earnings power and sector comparison. Neuland Laboratories Stock News today is therefore about price action, fundamentals and peer context rather than a fresh operating event.
Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 18,775 |
| Previous Close | Rs 19,224.5 |
| Today's Move | -Rs 449.50 (-2.34%) |
| Open | Rs 19,224.5 |
| High | Rs 19,305 |
| Low | Rs 18,775 |
| Market Capitalisation | Rs 24,664.82 crore |
| Market Cap Category | Large Cap |
Neuland Laboratories Share Price moved from the previous close of Rs 19,224.50 to Rs 18,775, a decline of Rs 449.50 or 2.34%. The stock opened at Rs 19,224.50, touched a high of Rs 19,305 and a low of Rs 18,775, so the current price is at the day’s low. In Large Cap terms, that is a meaningful intraday shift for Neuland Laboratories Share Price Today, even though the move is not being linked to any verified company event. Neuland Laboratories Share Price Fall can be read as a clean price action story: the stock started at the previous close, tried a higher print, and then settled into the lower end of the range as of 21 October 2026 at 9:53:14 AM IST. That makes Neuland Laboratories Share Price a clear stock to monitor for follow-through in the next update.
For market readers, Neuland Laboratories Share Price Today matters because the price, the opening level and the intraday range are all aligned to a single session of trading. Neuland Laboratories Share Price News also matters because the stock’s valuation and profitability ratios remain a large part of the discussion. With no second-session streak to factor in, the move is best viewed as the latest session’s decline and not as a multi-day pattern. That is why Univest places the next layer of analysis on fundamentals.
Neuland Laboratories (NEULANDLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 24,664.82 crore |
| P/E Ratio | 49.55x |
| P/B Ratio | 12.2x |
| ROE | 21.43% |
| ROCE | 27.5% |
| EPS | Rs 387.98 |
| Book Value Per Share | Rs 1,575.41 |
| Dividend Yield | 0.18% |
Neuland Laboratories (NEULANDLAB) fundamental metrics show P/E 49.55x, P/B 12.2x, ROE 21.43%, ROCE 27.5%. These ratios show where the company stands today and are not a call to buy or sell.
Neuland Laboratories has a market capitalisation of Rs 24,664.82 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.55x, P/B at 12.2x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.43% and ROCE of 27.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 387.98, book value per share of Rs 1,575.41, dividend yield of 0.18%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 49.55x |
| Benchmark Median P/E | 31.73x |
| Benchmark Average P/E | 45.98x |
| Benchmark P/E Range | 3.1x to 616.89x |
| Company P/B Ratio | 12.2x |
| Benchmark Median P/B | 2.76x |
| Benchmark Average P/B | 4.11x |
| Company ROE | 21.43% |
| Benchmark Median ROE | 11.33% |
| Benchmark Average ROE | 10.14% |
| Company ROCE | 27.5% |
| Benchmark Median ROCE | 13.25% |
| Benchmark Average ROCE | 13.05% |
| Company Market Capitalisation | Rs 24,664.82 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
| Benchmark Average Market Cap | Rs 13,467.03 crore |
Neuland Laboratories (NEULANDLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Neuland Laboratories (NEULANDLAB) has a P/E ratio of 49.55x, which is above the benchmark median of 31.73x, a difference of +56.16%. A P/E difference of this kind is a reference point rather than a recommendation.
Neuland Laboratories (NEULANDLAB) has a ROE of 21.43%, which is above the benchmark median of 11.33%, a difference of +89.14%. Neuland Laboratories (NEULANDLAB) has a ROCE of 27.5%, which is above the benchmark median of 13.25%, a difference of +107.55%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,41,310.94 | 82.5 | 13.66 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,078.79 | 79.36 | 19.28 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,11,433.99 | 101.92 | 19.76 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,022.18 | 24.6 | 4.12 | 19.69 | 21.39 |
Neuland Laboratories (NEULANDLAB) has a P/E ratio of 49.55x compared with the displayed peer median of 79.36x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.43% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 27.5% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Neuland Laboratories (NEULANDLAB) has a market capitalisation of Rs 24,664.82 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Neuland Laboratories
- Neuland Laboratories Share Price fell 2.34% to Rs 18,775, which makes today’s move a clear price action event.
- Neuland Laboratories Share Price Today remains in a Large Cap company with market capitalisation of Rs 24,664.82 crore.
- Neuland Laboratories Fundamental Analysis shows a P/E of 49.55 and a P/B of 12.2, both above the industry median.
- ROE of 21.43% and ROCE of 27.5% are above the healthcare benchmark medians, supporting the quality discussion.
- Neuland Laboratories Stock News today is driven by valuation, peer comparison and the day’s decline, not by a verified company event.
About Neuland Laboratories
Neuland Laboratories operates in the Pharmaceuticals & Drugs industry within Healthcare. The company is part of the listed Large Cap universe and is tracked for its earnings profile, return ratios and valuation multiples. Neuland Laboratories Share Price is therefore often discussed in relation to profitability metrics such as ROE, ROCE and EPS, along with book value and P/B. In the current context, the company is best viewed as a healthcare manufacturer whose stock is closely followed for financial performance and industry positioning rather than for a short-term trading narrative. Neuland Laboratories Share Price Today reflects that positioning clearly.
Track Neuland Laboratories Share Price on Univest
Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Neuland Laboratories Share Price on Univest for live price movement, fundamental ratios, 52-week levels and market insights in one place. Univest also helps readers follow Neuland Laboratories Stock News, Neuland Laboratories Share Price Today and Neuland Laboratories Fundamental Analysis with a consistent view of valuation and sector context. For investors who want a cleaner read on Neuland Laboratories Share Price, Univest brings the latest figures together without changing the underlying facts.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Neuland Laboratories Share Price falling today?
Ans. Neuland Laboratories Share Price is down 2.34% to Rs 18,775. The price move is confirmed in Univest data; a company-specific reason has not been established. The move is visible through today’s open, high, low and previous close.
What is Neuland Laboratories Share Price today?
Ans. Neuland Laboratories Share Price is Rs 18,775 as of 21 October 2026 at 9:53:14 AM IST. It traded below the previous close of Rs 19,224.50 and stayed within an intraday range of Rs 18,775 to Rs 19,305.
How much did Neuland Laboratories Share Price fall?
Ans. Neuland Laboratories Share Price fell Rs 449.50, which equals 2.34%. That decline came from the previous close of Rs 19,224.50 and left the stock at the day’s low of Rs 18,775 at the latest update.
What is Neuland Laboratories market capitalisation?
Ans. Neuland Laboratories has a market capitalisation of Rs 24,664.82 crore and is classified as a Large Cap. That size context matters when reading Neuland Laboratories Share Price, because valuation and peer comparison should be viewed against a large-company base.
Is Neuland Laboratories Share Price expensive versus peers?
Ans. Neuland Laboratories Share Price carries a P/E of 49.55 and a P/B of 12.2. Those ratios are above the healthcare industry medians of 31.73 and 2.76, so the valuation sits at a premium to the benchmark set.
How strong are Neuland Laboratories profitability ratios?
Ans. Neuland Laboratories reports ROE of 21.43% and ROCE of 27.5%. Both are above the healthcare benchmark medians, which is why Neuland Laboratories Fundamental Analysis remains relevant even after the day’s decline in Neuland Laboratories Share Price.
What does EPS tell investors about Neuland Laboratories Share Price?
Ans. EPS is Rs 387.98, which shows earnings attributable to each share. For Neuland Laboratories Share Price, this is an important context point because it helps explain why the stock trades at a higher P/E than the industry median.
What does book value mean for Neuland Laboratories?
Ans. Book value is Rs 1,575.41 per share. For Neuland Laboratories Share Price, that means the stock trades well above accounting net worth per share, which is consistent with the company’s premium P/B ratio of 12.2.
How can investors track Neuland Laboratories Share Price on Univest?
Ans. Investors can track Neuland Laboratories Share Price on Univest for live updates, fundamental ratios, 52-week levels and market insights. It is a useful way to follow Neuland Laboratories Stock News, valuation and sector context in one place.
